BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Heart
,
Nosology
,
Bleomycin
,
rs2476601
,
MYC
,
Metabolism of xenobiotics
,
Leukemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Anti- antibodies
NextBio Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Treatment of human Non-Hodgkins Lymphoma cell lines with agonistic antibodies
Influence of anti-CD25 mAb on the transcriptome of activated PBMC
CD4+ T cells stimulated and then restimulated in the presence or absence of natalizumab
PBMCs of myelopathy/tropical spastic paraparesis patients treated with Fas agonist/antagonist mAbs
Explore Curated Studies Results
Literature
Most Relevant Literature
Anti-citrullinated protein antibodies in patients with psoriatic arthritis.
Association of Sputum Neutrophil Extracellular Trap Subsets With IgA Anti-Citrullinated Protein Anti…
Predictors of unacceptable pain with and without low inflammation over 5 years in early rheumatoid a…
Clinical characteristics of multicentric reticulohistiocytosis and distinguished features from rheum…
Individuals at risk for rheumatoid arthritis harbor differential intestinal bacteriophage communitie…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Characterization of Anti-FGFR3 Antibodies
Diagnostic Utility of Anti MCV Antibodies,Anti CCPantibodies and RF in RA
Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid Tumors
Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC
Optimizing HBV Management During Anti-CD20 Antibodies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ